Diagnostic Approach for Mobitz Type II Second-Degree AV Block

Initial Evaluation and Management

The American College of Cardiology strongly recommends transthoracic echocardiography (Class I recommendation) for patients with newly identified Mobitz type II atrioventricular block to assess for underlying structural heart disease 1, 2
Patients presenting with lightheadedness and confirmed Mobitz Type II second-degree AV block on ECG warrant immediate evaluation for underlying cardiac pathology 1
Transcutaneous pacing pads should be placed as Mobitz Type II AV block has a higher risk of progression to complete heart block and hemodynamic compromise 3

Echocardiography can identify underlying structural heart disease that may be contributing to the conduction disorder, including ischemic heart disease 3, cardiomyopathy 4, valvular disease 4, and left ventricular dysfunction 1, 2
Patients with multiple cardiovascular risk factors (such as hypertension, diabetes, and hyperlipidemia) have an increased likelihood of underlying structural heart disease 5, 6

Laboratory tests based on clinical suspicion for potential underlying causes are reasonable (Class IIa recommendation) 1, 2
An electrolyte panel is appropriate to rule out electrolyte abnormalities that could contribute to conduction disorders 1, 7
Thyroid function tests may be considered if there is clinical suspicion for thyroid dysfunction 1
Lyme disease serology would only be indicated if there is clinical suspicion or relevant exposure history 1, 2

Nuclear stress testing would not be the first-line test in this scenario, though it may be considered later if ischemic heart disease is suspected after initial evaluation 1
Disease-specific advanced imaging (CT, MRI, nuclear imaging) is reasonable only if structural heart disease is suspected but not confirmed by echocardiography 1, 2

The presence of Mobitz Type II AV block in a patient with cardiovascular risk factors strongly suggests underlying structural heart disease and warrants thorough cardiac evaluation 1, 4
Mobitz Type II AV block is generally considered an indication for permanent pacemaker placement, particularly when symptomatic 4